Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,438,864
-$604,852 QoQ
Shares Held
142,810
-0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#756
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. PFE ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
This page
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
42,788 | $2,465,444 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,438,864 | 142,810 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,043,716 | 144,007 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,657,561 | 146,890 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,611,127 | 141,724 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,391,345 | 139,907 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,045,487 | 120,185 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,710,565 | 139,863 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,051,600 | 140,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,051,531 | 144,801 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,056,911 | 146,195 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,657,761 | 161,784 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,430,625 | 163,721 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $5,168,395 | 140,905 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,721,547 | 140,234 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,181,952 | 140,163 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,708,667 | 130,454 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,706,059 | 127,905 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,514,219 | 125,830 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $7,444,197 | 126,066 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,461,237 | 126,976 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $5,073,060 | 129,547 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,924,997 | 135,937 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,073,043 | 137,817 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,122,984 | 139,591 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,667,897 | 142,749 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,894,753 | 149,962 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||